B2MG
Mexico·Clase I·III. DIAGNOSTIC AGENTS·PRODUCTOS ROCHE, S.A. DEC.V.·Registered October 27, 2020PRUEBA IN VITRO PARA LA DETERMINACIÓNCUANTITATIVA DE LA B2- MICROGLOBULINA.(B2MG)ENSUERO,PLASMAYORINAHUMANOSEN LOS SISTEMAS ROCHE. AGENTES DEDIAGNÓSTICOPARAUSO INVITRO, PARAUSOEXCLUSIVOENLABORATORIOSCLÍNICOSÓDEGABINETE.
IN VITRO TEST FOR THE QUANTITATIVE DETERMINATION OF B2- MICROGLOBULIN. (B2MG) SERUM, PLASMA AND HUMAN URINE IN ROCHE SYSTEMS. DIAGNOSTIC AGENTS FOR INVITRO USE, FOR USE ONLY IN CLINICALLABORATORIES OR CABINET.
- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBA PARA LA DETERMINACIÓNDE LA B2- MICROGLOBULINA.
- Trade Name (English)
- TEST FOR THE DETERMINATION OF B2- MICROGLOBULIN.
- Analysis ID
- 1474R2020 SSA
- Registration Date
- October 27, 2020
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DEC.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DEC.V.
Access comprehensive regulatory information for B2MG (B2MG) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1474R2020 SSA and manufactured by PRODUCTOS ROCHE, S.A. DEC.V.. The device was registered on October 27, 2020.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.